MNPR

Monopar Therapeutics (MNPR)

Monopar Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MNPR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/11	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/11	20:30	GlobeNewswire Inc.	Monopar and NorthStar Amend & Extend Collaboration	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/10	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/10	21:00	GlobeNewswire Inc.	Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/06	07:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/01	05:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/31	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/25	05:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/24	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/24	21:00	GlobeNewswire Inc.	Monopar Announces CFO Succession	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/09	20:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/09	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/09	20:00	GlobeNewswire Inc.	Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/04/18	21:00	GlobeNewswire Inc.	Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/04/16	21:00	GlobeNewswire Inc.	Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/04/10	21:00	GlobeNewswire Inc.	Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/03/28	20:00	GlobeNewswire Inc.	Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/03/07	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/03/05	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/03/05	21:00	GlobeNewswire Inc.	Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/29	03:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/27	21:00	GlobeNewswire Inc.	Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/27	20:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/22	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/22	21:00	GlobeNewswire Inc.	Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/20	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/02/20	22:00	GlobeNewswire Inc.	Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/01/04	09:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/01/04	09:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2023/11/09	21:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MNPR	Monopar Therapeutics Inc